CLPT— ClearPoint Neuro, Inc.

Health Care$433M mkt cap

Metric	FY2025	FY2024	FY2023	FY2022
Total revenue	$37.0M+17.8%	$31.4M+31.0%	$24.0M+16.6%	$20.6M
Cost of revenue	$14.3M+16.4%	$12.3M+18.6%	$10.3M+47.3%	$7.0M
Gross profit	$22.7M+18.7%	$19.1M+40.5%	$13.6M+0.6%	$13.5M
Research and development costs	$13.9M+12.1%	$12.4M+5.8%	$11.7M+7.5%	$10.9M
Sales and marketing expenses	$16.5M+13.7%	$14.5M+15.0%	$12.6M+34.6%	$9.4M
General and administrative expenses	$16.5M+37.6%	$12.0M+2.0%	$11.8M+22.3%	$9.6M
Operating loss	-$24.2M-22.4%	-$19.7M+12.1%	-$22.4M-37.4%	-$16.3M
Other expense, net	-$146K-265.0%	-$40K-37.9%	-$29K-31.8%	-$22K
Interest income	$1.2M-12.7%	$1.4M	—	—
Interest expense	-$2.4M-361.0%	-$518K	—	—
Net loss before income taxes	-$25.5M-34.8%	-$18.9M	—	—
Income tax expense	$55K+358.3%	$12K	—	—
Net loss	-$25.5M-35.0%	-$18.9M+14.4%	-$22.1M-34.4%	-$16.4M
Basic (in dollars per share)	-$900.00-28.6%	-$700.00+22.2%	-$900.00-32.4%	-$680.00
Diluted (in dollars per share)	-$900.00-28.6%	-$700.00+22.2%	-$900.00-32.4%	-$680.00
Basic (in shares)	28.32B+4.8%	27.03B+9.8%	24.61B+1.8%	24.18B
Diluted (in shares)	28.32B+4.8%	27.03B+9.8%	24.61B+1.8%	24.18B
Product revenue
Service and other revenue

Source: SEC EDGAR XBRL. % change vs prior period shown where available.

Pro feature

Unlock 12 more years of annual history and full quarterly detail on Pro.

Source: SEC EDGAR 10-K and 10-Q filings. Last 4 years annual and quarterly free, full history (up to 20 years) on Pro.